India’s IPO market continues to attract strong participation from both retail and institutional investors. With the agricultural sector remaining a key pillar of the Indian economy, companies involved in agrochemicals and crop protection solutions are increasingly gaining investor attention. Rising global food demand, changing climate conditions, and the need to improve agricultural productivity are driving demand for innovative crop protection products.
Government initiatives supporting agricultural growth and increasing exports of agrochemicals have further strengthened India’s position in the global crop protection market. Against this backdrop, GSP Crop Science Limited is set to open its IPO on March 16, 2026. Here is a detailed insight into GSP Crop Science Limited, its IPO, and the industry outlook.
About GSP Crop Science Ltd.
Incorporated in 1985, GSP Crop Science Limited is an agrochemical company engaged in the manufacturing of insecticides, herbicides, fungicides, and plant growth regulators. The company provides crop protection solutions aimed at helping farmers improve agricultural productivity by offering products designed to control pests, weeds, and plant diseases.
The company develops and manufactures both Formulations and Technicals. Formulations consist of active ingredients and additives designed for agricultural use, while Technicals are concentrated active ingredients that are processed to create products such as insecticides, herbicides, and fungicides.
GSP Crop Science has a diverse portfolio of agrochemical products manufactured in house and distributed across India and international markets. During the six months ended September 30, 2025 and the fiscal years 2025, 2024, and 2023, the company served customers across 20 states in India.
The company also has a strong international presence, supplying products to 37 countries, including the United States, Brazil, Vietnam, Singapore, Uruguay, the UAE, and Australia.
Research and development plays a significant role in the company’s growth. As of September 30, 2025, GSP Crop Science had 524 registrations across formulations and technicals, along with 102 granted patents and 108 patent applications under process. The company operates dedicated R&D facilities in Kathwada and Odhav, focusing on testing, commercialisation, and development of complex agrochemical products.
As of September 30, 2025, the company employs 1,221 permanent employees.
GSP Crop Science Ltd. IPO Details
GSP Crop Science IPO is a book building issue of ₹400 crore. The issue consists of a fresh issue of 0.75 crore shares aggregating to ₹240 crore and an offer for sale of 0.50 crore shares aggregating to ₹160 crore.
The funds raised through the fresh issue will primarily be used to repay or prepay certain outstanding borrowings, while the remaining proceeds will be utilised for general corporate purposes.
Important IPO Timeline
| Event | Date |
|---|---|
| IPO Open Date | March 16, 2026 |
| IPO Close Date | March 18, 2026 |
| Allotment Date (Tentative) | March 20, 2026 |
| Initiation of Refunds | March 23, 2026 |
| Credit of Shares to Demat | March 23, 2026 |
| Listing Date (Tentative) | March 24, 2026 |
Key IPO Details
Here is the table on the GSP Crop Science IPO Review:
| Particulars | Details |
|---|---|
| Face Value | ₹10 per share |
| Issue Price Band | ₹304 to ₹320 per share |
| Lot Size | 46 Shares |
| Total Issue Size | 1,25,00,000 shares (aggregating up to ₹400 Cr) |
| Fresh Issue | 75,00,000 shares (aggregating up to ₹240 Cr) |
| Offer for Sale | 50,00,000 shares (aggregating up to ₹160 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing at | BSE, NSE |
| Shareholding Pre Issue | 3,90,18,750 shares |
| Shareholding Post Issue | 4,65,18,750 shares |
| Market Cap (Pre IPO) | ₹1,488.60 Cr |
Lot Size of GSP Crop Science Ltd. IPO
Here is the table of lot sizes for each category of investors:
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 46 | ₹14,720 |
| Retail (Max) | 13 | 598 | ₹1,91,360 |
| S-HNI (Min) | 14 | 644 | ₹2,06,080 |
| S-HNI (Max) | 67 | 3,082 | ₹9,86,240 |
| B-HNI (Min) | 68 | 3,128 | ₹10,00,960 |
GSP Crop Science Ltd. Financials
The GSP Crop Science IPO has a pre IPO market capitalisation of ₹1,488.60 crore. The company has demonstrated steady financial performance with growing revenue and profitability over recent years.
As of September 30, 2025, the company’s key performance indicators show a Return on Equity (ROE) of 15.62% and Return on Capital Employed (ROCE) of 15.45%. The company has maintained a PAT margin of 9.56% and an EBITDA margin of 16.45%, reflecting stable operating performance.
Key Company Financials
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | ₹1,491.69 Cr | ₹1,228.50 Cr | ₹980.34 Cr | ₹1,132.13 Cr |
| Total Income | ₹847.61 Cr | ₹1,301.06 Cr | ₹1,158.23 Cr | ₹1,206.05 Cr |
| Profit After Tax | ₹81.07 Cr | ₹81.42 Cr | ₹55.54 Cr | ₹17.57 Cr |
| EBITDA | ₹138.86 Cr | ₹164.03 Cr | ₹130.41 Cr | ₹81.28 Cr |
| Net Worth | ₹529.85 Cr | ₹450.03 Cr | ₹370.46 Cr | ₹363.47 Cr |
| Reserves and Surplus | ₹490.84 Cr | ₹411.02 Cr | ₹344.46 Cr | ₹336.00 Cr |
| Total Borrowing | ₹321.13 Cr | ₹295.60 Cr | ₹235.44 Cr | ₹324.26 Cr |
GSP Crop Science Ltd.: Industry Outlook
• The global agrochemical market is witnessing strong growth due to increasing demand for food security and improved crop productivity.
• Rising population and shrinking agricultural land are pushing farmers to adopt crop protection chemicals and advanced farming solutions.
• India is emerging as a major global supplier of agrochemicals due to cost competitive manufacturing and growing export opportunities.
• The Indian agrochemical industry is expected to expand steadily, supported by increasing exports to Latin America, Asia Pacific, and North America.
• Investments in research and development are enabling agrochemical companies to develop innovative products and improve crop protection efficiency.
Conclusion
GSP Crop Science Limited operates in the agrochemical industry with a diversified portfolio of crop protection products, including insecticides, herbicides, fungicides, and plant growth regulators. The company benefits from strong R&D capabilities, a wide global presence, and an established product portfolio.
However, investors should also consider certain risks. The agrochemical industry is highly competitive and subject to regulatory approvals and environmental considerations. Based on the company’s recent financial performance and valuation metrics, the IPO appears reasonably priced.
Well informed investors may consider evaluating the opportunity carefully and may invest with a medium to long term perspective.
